Skip to main content

Solid Lipid Nanoparticles

  • Chapter
Nanocarrier Technologies

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barratt, G.M. Therapeutic applications of colloidal drug carriers. Pharmaceutical Science & Technology Today, 2000. 3(5): 163-171.

    Article  CAS  Google Scholar 

  2. Barratt, G. Colloidal drug carriers: achievements and perspectives. Cellular and Molecular Life Sciences (CMLS), 2003. 60(1): 21-37.

    Article  CAS  Google Scholar 

  3. Zweers, M.L., Engbers, G.H., Grijpma, D.W. and Feijen, J. In vitro degradation of nanoparticles prepared from polymers based on DL-lactide, glycolide and poly(ethylene oxide). Journal of Controlled Release, 2004. 100(3): 347-356.

    Article  CAS  PubMed  Google Scholar 

  4. Muller, R.H., Maassen, S., Weyhers, H., Specht, F. and Lucks, J.S. Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles. International Journal of Pharmaceutics, 1996. 138(1): 85-94.

    Article  Google Scholar 

  5. Schwarz, C., Mehnert, W., Lucks, J.S. and Muller, R.H. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. Journal of Controlled Release, 1994. 30(1): 83-96.

    CAS  Google Scholar 

  6. Muller, R.H., Ruhl, D., Runge, S., SchulzeForster, K. and Mehnert, W. Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant. Pharmaceutical Research, 1997. 14(4): 458-462.

    Article  CAS  PubMed  Google Scholar 

  7. Heydenreich, A.V., Westmeier, R., Pedersen, N., Poulsen, H.S. and Kristensen, H.G. Preparation and purification of cationic solid lipid nanospheres-effects on particle size, physical stability and cell toxicity. International Journal of Pharmaceutics, 2003. 254(1): 83-87.

    Article  CAS  PubMed  Google Scholar 

  8. Gohla, S.H. and Dingler, A. Scaling up feasibility of the production of solid lipid nanoparticles (SLN). Die Pharmazie, 2001. 56(1): 61-63.

    CAS  PubMed  Google Scholar 

  9. Ugazio, E., Cavalli, R. and Gasco, M.R. Incorporation of cyclosporin A in solid lipid nanoparticles (SLN). International Journal of Pharmaceutics, 2002. 241(2): 341-344.

    Article  CAS  PubMed  Google Scholar 

  10. Trotta, M., Debernardi, F. and Caputo, O. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. International Journal of Pharmaceutics, 2003. 257 (1-2): 153-160.

    Article  CAS  PubMed  Google Scholar 

  11. Venkateswarlu, V. and Manjunath, K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. Journal of Controlled Release, 2004. 95 (3): 627-638.

    Article  CAS  PubMed  Google Scholar 

  12. Lim, S.J. and Kim, C.K. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. International Journal of Pharmaceutics, 2002. 243(1-2): 135-146.

    Article  CAS  PubMed  Google Scholar 

  13. Mehnert, W. and Mader, K. Solid lipid nanoparticles: Production, characterization and applications. Advanced Drug Delivery Reviews, 2001. 47(2-3): 165-196.

    Article  CAS  PubMed  Google Scholar 

  14. Bunjes, H., Westesen, K. and Koch, M.H.J. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. International Journal of Pharmaceutics, 1996. 129 (1-2): 159-173.

    Article  CAS  Google Scholar 

  15. Muehlen, A.Z., Muehlen, E.Z., Niehus, H. and Mehnert, W. Atomic Force Microscopy Studies of Solid Lipid Nanoparticles. Pharmaceutical Research, 1996. 13(9): 1411-1416.

    Article  Google Scholar 

  16. Westesen, K., Bunjes, H. and Koch, M.H.J. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. Journal of Controlled Release, 1997. 48(2-3): 223-236.

    Article  CAS  Google Scholar 

  17. Cavalli, R., Caputo, O., Carlotti, M.E., Trotta, M., Scarnecchia, C. and Gasco, M.R. Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. International Journal of Pharmaceutics, 1997. 148(1): 47-54.

    Article  CAS  Google Scholar 

  18. Lippacher, A., Muller, R.H. and Mader, K. Semisolid SLN(TM) dispersions for topical application: influence of formulation and production parameters on viscoelastic properties. European Journal of Pharmaceutics and Biopharmaceutics,2002. 53(2): 155-160.

    Article  CAS  PubMed  Google Scholar 

  19. Wissing, S.A. and Muller, R.H. The influence of solid lipid nanoparticles on skin hydration and viscoelasticity - in vivo study. European Journal of Pharmaceutics and Biopharmaceutics, 2003. 56(1): 67-72.

    Article  CAS  PubMed  Google Scholar 

  20. Wissing, S.A. and Muller, R.H. Cosmetic applications for solid lipid nanoparticles (SLN). International Journal of Pharmaceutics, 2003. 254(1): 65-68.

    Article  CAS  PubMed  Google Scholar 

  21. Jenning, V., Gysler, A., Schafer-Korting, M. and Gohla, S.H. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. European Journal of Pharmaceutics and Biopharmaceutics, 2000. 49(3): 211-218.

    Article  CAS  PubMed  Google Scholar 

  22. Saupe, A., Pharmaceutical and cosmetic applications of nanostructured lipid carriers (NLC): sun protection and care. 2004, Free University of Berlin.

    Google Scholar 

  23. Pouton, C.W., Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. European Journal of Pharmaceutical Sciences, 2000. 11(Supplement 2): S93-S98.

    Article  CAS  PubMed  Google Scholar 

  24. Yang, S., Zhu, J., Lu, Y., Liang, B. and Yang, C. Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration. Pharmaceutical Research, 1999. 16 (5): 751-757.

    Article  CAS  PubMed  Google Scholar 

  25. Mei, Z., Li, X., Wu, Q., Hu, S. and Yang, X. The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle. Pharmacological Research, 2005. 51(4): 345-351.

    Article  CAS  PubMed  Google Scholar 

  26. Zara, G.P., Cavalli, R., Fundaro, A., Bargoni, A., Caputo, O. and Gasco, M.R. Pharmacokinetics of Doxorubicin incorporated in solid lipid nanosheres (SLN). Pharmacological Research, 1999. 40(3): 281-286.

    Article  CAS  PubMed  Google Scholar 

  27. Olbrich, C., Mueller, R.H., Tabatt, K., Kayser, O., Schulze, C. and Schade, R. Stable biocompatible adjuvants--a new type of adjuvant based on solid lipid nanoparticles: a study on cytotoxicity, compatibility and efficacy in chicken. Altern. Lab. Anim., 2002. 30 (4): 443-58.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer

About this chapter

Cite this chapter

Saupe, A., Rades, T. (2006). Solid Lipid Nanoparticles. In: Mozafari, M.R. (eds) Nanocarrier Technologies. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-5041-1_3

Download citation

Publish with us

Policies and ethics